Telbivudine: A new treatment for chronic hepatitis B

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

260

HTML

2298

Figures (1-2)

172

Tables (1-4)

156

Sum=2886

Dec 14, 2007 (publication date) through Apr 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 14, 2007; 13(46): 6150-6155
Published online Dec 14, 2007. doi: 10.3748/wjg.v13.i46.6150

Full Size Figure Download Figure

Figure 1 Median reductions in serum hepatitis B virus (HBV) DNA levels at wk 52 (log10 copies/mL) in all treatment groups.

Citation: Amarapurkar DN. Telbivudine: A new treatment for chronic hepatitis B. World J Gastroenterol 2007; 13(46): 6150-6155
URL: https://www.wjgnet.com/1007-9327/full/v13/i46/6150.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i46.6150